BioAmber Inc. 4
4 · BioAmber Inc. · Filed Jan 28, 2016
Insider Transaction Report
Form 4
BioAmber Inc.BIOA
Huc Jean-Francois
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2016-01-26+200,000→ 200,000 totalExercise: $5.00Exp: 2026-01-26→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The exercise price represents a premium of $0.86 per share over grant date closing market price of BioAmber Inc. common stock on the New York Stock Exchange of $4.14 per share.
- [F2]These options will vest as follows: 25% will vest on 01/26/2017; the remaining 75% will vest on a monthly basis over the three (3) following years.